Exploring the efficacy of PARP inhibitors in metastatic castration-resistant prostate cancer with homologous recombination repair alteration: a meta-analysis based on subgroups and reconstructed individual patient data
2025International Journal of SurgeryJournalOpen access
10.1097/js9.0000000000003338Full text3 citations